A randomized trial of inhaled levodopa (CVT‐301) for motor fluctuations in Parkinson's disease

201689 citationsJournal Articlehybrid Open Access

Authors

Peter A. LeWitt · Wayne State University

Robert A. Hauser · University of South Florida

Donald G. Grosset · University of Glasgow

Fabrizio Stocchi · Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Marie Saint‐Hilaire · Boston University

Aaron Ellenbogen · Michigan Institute for Neurological Disorders

Mika Leinonen

Abstract

CVT-301 self-administered during OFF episodes provided rapid improvement of motor function, and daily OFF time was significantly reduced at the higher dose. CVT-301 was generally safe and well-tolerated. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Topics & Keywords

Neurological disorders and treatments Parkinson's Disease Mechanisms and Treatments Restless Legs Syndrome Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Movement Disorders

Volume 31, Issue 9, pp. 1356-1365

DOI: 10.1002/mds.26611

Field-Weighted Citation Impact: 8.41